Lipocine Inc.
LPCN
$3.52
$0.21346.45%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/10/2025
-
Zolmax
4/4/2025
-
TipRanks Financial Blog
4/2/2025
-
Ticker Report
3/26/2025
-
GuruFocus
3/26/2025
-
The Fly
3/26/2025
-
PR Newswire
3/23/2025
-
Ticker Report
3/19/2025
-
The Fly
3/15/2025
-
Ticker Report
3/13/2025
-
GuruFocus
3/13/2025
-
SeekingAlpha.com: All News
3/13/2025
-
PR Newswire
3/12/2025
-
GuruFocus
3/12/2025
-
The Fly
3/12/2025
-
PR Newswire
2/27/2025
-
Ticker Report
2/11/2025
-
Ticker Report
2/6/2025
-
GuruFocus
2/6/2025
-
The Fly
2/6/2025
-
PR Newswire
2/2/2025
-
Ticker Report
1/27/2025
-
Ticker Report
1/17/2025
-
Ticker Report
1/11/2025
-
Ticker Report
1/9/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
801 994 7383
Address
675 Arapeen Drive
Salt Lake City, UT 84108
Salt Lake City, UT 84108
Country
Year Founded
Business Description
Sector
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead...
more